THE IMPACT OF ENDOCRINE PATHOLOGY ON THE OUTCOMES OF IN VITRO FERTILIZATION PROCEDURE
Clinical medicine

THE IMPACT OF ENDOCRINE PATHOLOGY ON THE OUTCOMES OF IN VITRO FERTILIZATION PROCEDURE

Published 2024-05-15

Authors:

A.F. Safarova

Abstract:
The purpose of the study was to find out the influence of endocrine disorders of women on the results of in vitro fertilization procedure. We observed 191 patients undergoing treatment for infertility. Of these, 146 (76.4%) were aged 20–35 years, 45 (23.6%) were aged 36-50 years. The presence and structure of endocrine pathologies and the outcomes of in vitro fertilization were analyzed in the patients. In the structure of somatic diseases in women underwent in vitro fertilization procedure, endocrine pathology predominated: in total 14 of 20 (70 %), 12 (60 %) women had hypothyroidism, 2 (10 %) had type 2 diabetes mellitus. Almost all women with endocrine pathology (12 cases of 14–85.7 %) demonstrated unsuccessful IVF results: a higher IVF failure rate based on absence of transfer was observed in women with hypothyroidism, and based on cycle disruption–in persons with type 2 diabetes mellitus.
Keywords:
assisted reproductive technologies hypothyroidism diabetes mellitus pregnancy
References:
  1. Artasensi A, Pedretti A, Vistoli G, Fumagalli L. Type 2 diabetes mellitus: A review of multi-target drugs. Molecules. 2020; 25(8):1987. doi: 10.3390/molecules25081987
  2. Fauque P, De Mouzon J, Devaux A, Epelboin S, Gervoise-Boyer MJ, Levy R, et al. Reproductive technologies, female infertility, and the risk of imprinting-related disorders. Clin Epigenetics. 2020 Dec 11;12(1):191. doi: 10.1186/s13148-020-00986-3.
  3. Herman T, Csehely S, Orosz M, Bhattoa HP, Deli T, Török P, et al. Endokrin kórképek elofordulása és társulása in vitro fertilizációs programban részt vevo nok körében [Prevalence and association of endocrine disorders in women participating in an in vitro fertilization program]. Orv Hetil. 2022 May 1;163(18):712–719. doi: 10.1556/650.2022.32372. [In Hungarian]
  4. Herman T, Csehely S, Orosz M, Bhattoa HP, Deli T, Torok P, et al. Impact of Endocrine Disorders on IVF Outcomes: Results from a Large, Single-Centre, Prospective Study. Reprod Sci. 2023 Jun;30(6):1878–1890. doi: 10.1007/s43032-022-01137-0.
  5. Lambrinoudaki I, Paschou SA, Armeni E, Goulis DG. The interplay between diabetes mellitus and menopause: clinical implications. Nat Rev Endocrinol. 2022; 18(10):608–22. doi: 10.1038/s41574-022-00708-0
  6. Mattsson K, Nilsson-Condori E, Elmerstig E, Vassard D, Schmidt L, Ziebe S, et al. Fertility outcomes in women with pre-existing type 2 diabetes–a prospective cohort study. Fertility Sterility. 2021; 116(2):505–13. doi: 10.1016/j.fertnstert.2021.02.009
  7. McGrogan A, Snowball J, de Vries CS. Pregnancy losses in women with type 1 or type 2 diabetes in the uk: an investigation using primary care records. Diabetes Med (2014) 31(3):357–65. doi: 10.1111/dme.12332
  8. Mintziori G, Goulis DG, Kolibianakis EM. Thyroid function and IVF outcome: when to investigate and when to intervene. Curr Opin Obstet Gynecol. 2016; 28:191–197. doi: 10.1097/GCO.0000000000000263.
  9. Poppe K, Veltri F, Autin C. Does levothyroxine improve pregnancy outcomes in euthyroid women with thyroid autoimmunity undergoing assisted reproductive technology? Thyroid Res. 2018;30(11):7. doi: 10.1186/s13044-018-0052-y.
  10. Qin X, Du J, He R, Li Y, Zhu Q, Li Y, et al. Adverse effects of type 2 diabetes mellitus on ovarian reserve and pregnancy outcomes during the assisted reproductive technology process. Front Endocrinol (Lausanne). 2023 Nov 15; 14:1274327 doi: 10.3389/fendo.2023.1274327.
  11. Ringholm L, Damm P, Mathiesen ER. Improving pregnancy outcomes in women with diabetes mellitus: modern management. Nat Rev Endocrinol. 2019; 15(7):406–16. doi: 10.1038/s41574-019-0197-3
  12. Tavakolian Arjmand A, Nouri M, Tavakolian Arjmand S. Surprisingly low infertility rate in married type 2 diabetic women: A rather curious paradox to the current opinion of insulin resistance as the joint pathogenesis of poly cystic ovary syndrome and type 2 diabetes mellitus. Diabetes Metab Syndr. 2015; 9(4):201–4. doi: 10.1016/j.dsx.2015.08.007
  13. Thong EP, Codner E, Laven JSE, Teede H. Diabetes: A metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 2020; 8(2):134–49. doi: 10.1016/S2213-8587(19)30345-6
  14. Venables A, Wong W, Way M, Homer HA. Thyroid autoimmunity and IVF/ICSI outcomes in euthyroid women: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2020; 18:120. doi: 10.1186/s12958-020-00671-3.
  15. Zhao J, Hong X, Zhang H, Dai Q, Huang K, Zhang X, et al. Pre-pregnancy maternal fasting plasma glucose levels in relation to time to pregnancy among the couples attempting first pregnancy. Hum Reprod. 2019; 34(7):1325–33. doi: 10.1093/humrep/dez069
Publication:
«World of Medicine and Biology» Vol. 20 No. 88 (2024) , с. 138-141
УДК 618.177:616-08